RETRACTED: Functional quantum dot-siRNA nanoplexes to regulate chondrogenic differentiation of mesenchymal stem cells
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
SOX9 plays an important role in mesenchymal condensations during the early development of embryonic skeletons. However, its function in the chondrogenic differentiation of adult mesenchymal stem cells (MSCs) has not been fully investigated because SOX9 RNA interference in adult MSCs has seldom been studied. This study used SOX9 gene as the target gene and the quantum dot (QD)-based nanomaterial QD-NH2 (ZnS shell and poly-ethylene glycol (PEG) coating) with a fluorescent tracer function as the gene carrier to transfect siSOX9 into MSCs after sulfosuccinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC) activation in vitro and in vivo. The results showed that QD-SMCC could effectively bind and deliver siRNAs into the MSCs, followed by efficient siRNA escape from the endosomes. The siRNAs released from QD-SMCC retained their structural integrity and could effectively inhibit the targeted gene expression, leading to reduced chondrogenic differentiation of MSCs and delayed cartilage repair. QDs were excreted from living cells instead of dead cells, and the ZnS shell and PEG coating layer greatly reduced the cytotoxicity of the QDs. The transfection efficiency of QD-SMCC was superior to that of polyethylenimine (PEI). In addition, QD-SMCC has an intrinsic signal for noninvasive imaging of siRNA transport. The results indicate that SOX9 is imperative for the chondrogenesis of MSCs and QD-SMCC has great potential for real-time tracking of transfection. Statement of significance In this study, we developed functional quantum dot (QD) nanoplexes by sulfosuccinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC) activation of PEG-coated CdSe/ZnS QDs as the gene carrier of siRNA to study the effect of SOX9 RNA interference on the chondrogenic differentiation of MSCs. This study confirmed the importance of SOX9 in chondrogenesis, as evidenced by the findings that SOX9 knockdown significantly inhibited the expression of cartilage-specific markers including acan and col2a1 in MSCs and further delayed cartilage repair. Moreover, QD-SMCC has an intrinsic signal for noninvasive imaging of siRNA transport. The results indicate that SOX9 is imperative for the chondrogenesis of MSCs and QD-SMCC has great potential for real-time tracking of transfection.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Osteoarthritis Treatment and Mechanisms · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Sox9 is required for cartilage formation10.1038/8792 ↗
2. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC610.1074/jbc.275.15.10738 ↗
3. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse10.1006/dbio.1996.8487 ↗
4. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference10.1016/j.biomaterials.2006.11.018 ↗
5. Lentiviral vector-mediated RNA silencing in the central nervous system10.1089/hgtb.2013.016 ↗
6. Current prospects for RNA interference-based therapies10.1038/nrg2968 ↗
7. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA10.1021/nn800280r ↗
8. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis10.1016/j.biomaterials.2010.08.086 ↗
9. Synergetic targeted delivery of sleeping-beauty transposon system to mesenchymal stem cells using LPD nanoparticles modified with a phage-displayed targeting peptide10.1002/adfm.201102963 ↗
10. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells10.1016/j.biomaterials.2014.05.092 ↗
11. Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier10.1021/bc700477u ↗
12. Physicochemical and in vitro biocompatibility evaluation of water-soluble CdSe/ZnS core/shell10.1177/0885328213499194 ↗
13. Quantum dot-related genotoxicity perturbation can be attenuated by PEG encapsulation10.1016/j.mrgentox.2013.01.006 ↗
14. Quantum dots to monitor RNAi delivery and improve gene silencing10.1093/nar/gni188 ↗
15. Capillary electrophoresis for the characterization of quantum dots after non-selective or selective bioconjugation with antibodies for immunoassay10.1186/1477-3155-6-10 ↗
16. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry10.1038/nprot.2007.107 ↗
17. In vivo cancer targeting and imaging with semiconductor quantum dots10.1038/nbt994 ↗
18. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery10.1021/nl9009793 ↗
19. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots10.1038/nbt764 ↗
20. Delivery of quantum dot-siRNA nanoplexes in SK-N-SH cells for BACE1 gene silencing and intracellular imaging10.1038/mtna.2012.11 ↗
21. The effect of quantum dot size and poly(ethylenimine) coating on the efficiency of gene delivery into human mesenchymal stem cells10.1016/j.biomaterials.2014.06.024 ↗
22. Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery10.1021/bc980148w ↗
23. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots10.1007/s00109-004-0629-x ↗
24. On the cyto-toxicity caused by quantum dots10.1111/j.1348-0421.2004.tb03478.x ↗
25. Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells10.1021/nn101277w ↗
26. Real time observation and kinetic modeling of the cellular uptake and removal of silicon quantum dots10.1016/j.biomaterials.2012.03.029 ↗
27. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes10.1021/nl070363y ↗
28. ABCG2 – a transporter for all seasons10.1016/j.febslet.2004.03.123 ↗
29. A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation10.1016/j.taap.2005.07.018 ↗
30. Cellular uptake, elimination and toxicity of CdSe/ZnS quantum dots in HepG2 cells10.1016/j.biomaterials.2013.08.038 ↗
31. In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review10.1007/s00204-009-0505-0 ↗
32. Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies10.1021/ar300040z ↗
33. On the generation of free radical species from quantum dots10.1002/smll.200500105 ↗
34. In vivo quantum-dot toxicity assessment10.1002/smll.200900626 ↗